GlySens Incorporated is a privately held corporation that is committed to developing a long term glucose sensor system to continuously monitor glucose levels and enhance the care and treatment of diabetes.

The GlySens approach employs a long term, fully implanted sensor that is unobtrusive and functions automatically and continuously, transmitting its signal wirelessly to points of need, which can include other devices configured to use the glucose signal, such as an external monitor. The sensor is intended to enable the introduction of new medical device systems to significantly improve the lives of people living with diabetes. The Company's unique position in the field is built upon a solid foundation of scientific and engineering achievements, and a team of dedicated managers, scientists, engineers, and support staff with a demonstrated record of success in the development and introduction of new technologies for continuous glucose monitoring.